JAMES ANTHONY CANNON Insider Trading $ZIOP ZIOPHARM ONCOLOGY INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JAMES ANTHONY CANNON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JAMES ANTHONY CANNON. JAMES ANTHONY CANNON is Director in ZIOPHARM ONCOLOGY INC ($ZIOP).
JAMES ANTHONY CANNON in ZIOPHARM ONCOLOGY INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JAMES ANTHONY CANNON: Director
Holdings: 398,050 shares
Current Value: $2,666,935
Latest Transaction: May 08 2019
$ZIOP Market Capitalization: $850.83M
$ZIOP Previous Close: $6.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JAMES ANTHONY CANNON in ZIOPHARM ONCOLOGY INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 08 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | M | 0.70 | 15,000 | 10,500 | 0 | |
| May 08 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Buy | M | 0.70 | 15,000 | 10,500 | 398,050 | 383.1 K to 398.1 K (+3.92 %) |
| May 08 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | M | 0.70 | 15,000 | 10,500 | 0 | |
| May 08 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Buy | M | 0.70 | 15,000 | 10,500 | 398,050 | 383.1 K to 398.1 K (+3.92 %) |
| Jan 02 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | A | 1.87 | 126,700 | 236,929 | 126,700 | |
| Jan 02 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 1.66 | 4,315 | 7,163 | 383,050 | 387.4 K to 383.1 K (-1.11 %) |
| Dec 13 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | M | 2.73 | 20,000 | 54,600 | 0 | |
| Dec 13 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 4.17 | 13,094 | 54,602 | 374,408 | 387.5 K to 374.4 K (-3.38 %) |
| Dec 13 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Buy | M | 2.73 | 20,000 | 54,600 | 387,502 | 367.5 K to 387.5 K (+5.44 %) |
| Jun 14 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | M | 4.85 | 15,000 | 72,750 | 0 | |
| Jun 14 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Buy | M | 4.85 | 15,000 | 72,750 | 367,502 | 352.5 K to 367.5 K (+4.26 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 5.35 | 6,665 | 35,658 | 352,502 | 359.2 K to 352.5 K (-1.86 %) |
| Jan 04 2017 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 17,204 | 0 | 359,167 | 342 K to 359.2 K (+5.03 %) |
| Apr 22 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | M | 5.01 | 15,000 | 75,150 | 0 | |
| Apr 22 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Buy | M | 5.01 | 15,000 | 75,150 | 341,963 | 327 K to 342 K (+4.59 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 26,661 | 0 | 326,963 | 300.3 K to 327 K (+8.88 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 8.31 | 4,177 | 34,711 | 300,302 | 304.5 K to 300.3 K (-1.37 %) |
| Jan 05 2016 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 8.31 | 1,462 | 12,149 | 304,479 | 305.9 K to 304.5 K (-0.48 %) |
| Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 16,707 | 0 | 301,124 | 284.4 K to 301.1 K (+5.87 %) |
| Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 5.07 | 6,167 | 31,267 | 284,417 | 290.6 K to 284.4 K (-2.12 %) |
| Jan 02 2015 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 5.03 | 1,465 | 7,369 | 290,584 | 292 K to 290.6 K (-0.50 %) |
| Jan 03 2014 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 18,818 | 0 | 294,976 | 276.2 K to 295 K (+6.81 %) |
| Jan 03 2013 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Payment of Exercise | F | 4.21 | 1,465 | 6,168 | 276,158 | 277.6 K to 276.2 K (-0.53 %) |
| Jan 03 2013 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 17,546 | 0 | 277,623 | 260.1 K to 277.6 K (+6.75 %) |
| Jan 04 2012 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 17,577 | 0 | 260,077 | 242.5 K to 260.1 K (+7.25 %) |
| Jan 04 2011 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | A | 4.77 | 30,000 | 143,100 | 30,000 | |
| Apr 01 2010 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | A | 5.09 | 15,000 | 76,350 | 15,000 | |
| Apr 01 2010 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 15,000 | 0 | 242,500 | 227.5 K to 242.5 K (+6.59 %) |
| Jan 05 2010 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | A | 2.85 | 7,500 | 21,375 | 7,500 | |
| Jan 05 2010 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 7,500 | 0 | 227,500 | 220 K to 227.5 K (+3.41 %) |
| Dec 11 2009 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | P | 4.02 | 87,500 | 351,750 | 87,500 | |
| Dec 11 2009 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Buy | P | 3.10 | 175,000 | 542,500 | 220,000 | 45 K to 220 K (+388.89 %) |
| Sep 24 2009 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.00 | 30,000 | 0 | 45,000 | 15 K to 45 K (+200.00 %) |
| May 15 2009 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | A | 0.70 | 15,000 | 10,500 | 15,000 | |
| Dec 05 2008 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Grant | A | 0.83 | 15,000 | 12,450 | 15,000 | 0 to 15 K |
| Dec 19 2007 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | A | 2.73 | 20,000 | 54,600 | 20,000 | |
| Jun 19 2007 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | A | 4.85 | 15,000 | 72,750 | 15,000 | |
| Jan 23 2007 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | A | 6.49 | 15,000 | 97,350 | 15,000 | |
| Apr 28 2006 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | A | 5.01 | 15,000 | 75,150 | 15,000 | |
| Sep 16 2005 | ZIOP | ZIOPHARM ONCOLOGY ... | CANNON JAMES ANTHONY | Director | Option Exercise | J | 4.31 | 15,029 | 64,775 | 15,029 |
Page: 1